Small-molecule therapeutics that mimic neurotrophic factors MANF and CDNF to selectively target injured/stressed cells and minimize side effects. Intended to treat diabetes, Parkinson’s disease, and ALS by enhancing cell survival, regulating protein folding, and reducing inflammation.